Quintiles says it is confident that all proper procedures were followed during a 2006 study of Theravance’s antibiotic telvancin being audited by Indian drug regulators.
MRSA could be treated through a combination of an antimicrobial drug, a peptide and light, according to researchers who have hailed the treatment as a “magic bullet”.
Nabi Biopharmaceuticals has announced the creation of the second of
its two new business units, Nabi Pharmaceuticals, a month after
spinning off its Biologics segment.
Researchers have demonstrated the effectiveness of a new drug for
treating infections caused by Staphylococcus aureus bacteria
representing the first drug of its kind to be FDA approved in two
decades.
Arpida has announced it has successfully completed a Phase I
clinical trial with oral iclaprim in a capsule formulation. This
broad-spectrum antibiotic targets infections requiring hospital
treatment, including those caused by methicillin-resistant...
Acolyte Biomedica introduces a new platform for its MRSA test,
which promises to set the benchmark for laboratory-based screening
of the bacterium by confirming negatives in five hours and
positives within 24 hours.
The latest research included in the proceedings of the Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC) means
that antibiotic treatments and management therapies feature
strongly in DrugResearcher’s round-up...
Greenbridge Environmental Control of the UK has introdueced a new
cleaner and disinfectant agent, suitable for commercial scale
applications, that is claimed to be the first non-toxic product of
its type.
Data from the first drug in a new class of antibiotics was
presented at this year's ECCMID conference, which showed the drug
demonstrated its efficacy against a wide variety of gram-positive
and gram-negative bacteria including...
Researchers have identified a promising new drug target in their
fight against resilient Staphylococcus bacteria that can be
transmitted to patients in hospitals via contaminated medical
implants.
The US Food and Drug Administration (FDA) has given clearance to a
new product, which simplifies the process, offers improved
specificity and decreases the time to result in the identification
of methicillin-resistant Staphyloccus...
Researchers have identified and tested an anti-sense
oligonucleotide sequence that will kill strains of Methicillin
Resistant (MRSA) and Vancomycin-resistant (VRSA) Staphylococcus
aureus, which continue to cause a serious public health...
A laboratory test that is able to detect methicillin resistant
Staphylococcus aureus (MRSA) a day earlier then traditional
antimicrobial susceptibility testing (AST) gives fresh impetus to
treatment and infection control efforts that...
A yeast encapsulation technology developed by UK company Micap is
at the heart of a new strategy for controlling
methicillin-resistant Staphylococcus aureus, the 'superbug'
that is emerging as a major threat in hospitals...
Nabi Biopharmaceuticals saw biopharmaceutical product sales -
driven by strong growth in sales of Nabi-HB - reaching record
levels of $89.5 million (€83m) in 2002, a 22 per cent increase from
2001 levels.